Sotera Health Company Common Stock insider trading
SHCfinancial statementsForm 4 filings on EDGAR83 transactions since Nov 16, 2024
From August 19, 2026 to November 16, 2026, 0 insiders at Sotera Health Company Common Stock bought $0 of stock in the open market, and 0 sold $0. Officers and directors accounted for $0 of purchases and $0 of sales. The last reported transaction was an open-market sale by Petras Michael B. Jr. on August 17, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through August 19, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $0Aug 19, 2026 – Nov 16, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 13, 2026. Insider data through Nov 16, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
83 transactions from November 16, 2024 to November 16, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Petras Michael B. Jr. | Executive Chairman, Director | open-market sale | 294,515 | $18.50 | $5M | 397,912 | Aug 19, 2026 |
| Aug 17, 2026 | Petras Michael B. Jr. | Executive Chairman, Director | open-market saleindirect | 850,000 | $18.50 | $16M | 4M | Aug 19, 2026 |
| Aug 7, 2026 | Rutz Michael P | President of Sterigenics | open-market sale | 150,000 | $18.84 | $3M | 334,279 | Aug 11, 2026 |
| Aug 5, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | tax withholding | 11,316 | $17.98 | $203K | 217,304 | Aug 7, 2026 |
| May 26, 2026 | Shader Alton | Chief Executive Officer, Director | award | 375,939 | $0.00 | — | 375,939 | May 27, 2026 |
| May 26, 2026 | Shader Alton | Chief Executive Officer, Director | award | 203,634 | $0.00 | — | 579,573 | May 27, 2026 |
| May 22, 2026 | Klee Ann R. | Director | award | 14,970 | $0.00 | — | 140,926 | May 27, 2026 |
| May 22, 2026 | Kyle Richard G | Director | award | 14,970 | $0.00 | — | 14,970 | May 27, 2026 |
| May 22, 2026 | Krause Kenneth D. | Director | award | 14,970 | $0.00 | — | 14,970 | May 27, 2026 |
| May 22, 2026 | Cunningham Sean Laurence | Director | award | 14,970 | $0.00 | — | 95,751 | May 27, 2026 |
| May 22, 2026 | Flynn Karen | Director | award | 14,970 | $0.00 | — | 54,191 | May 27, 2026 |
| May 22, 2026 | Neary James | Director | award | 14,970 | $0.00 | — | 95,751 | May 27, 2026 |
| May 22, 2026 | Petrella Vincent K | Director | award | 14,970 | $0.00 | — | 95,751 | May 27, 2026 |
| May 22, 2026 | Chen Ruoxi | Director | award | 14,970 | $0.00 | — | 95,751 | May 27, 2026 |
| May 22, 2026 | Simon, Christopher | Director | award | 14,970 | $0.00 | — | 34,102 | May 27, 2026 |
| May 22, 2026 | Wheadon David E. | Director | award | 14,970 | $0.00 | — | 89,882 | May 27, 2026 |
| May 13, 2026 | Warburg Pincus & CO.+7 more | Director, 10% owner | open-market saleindirect | 19M | $15.17 | $290M | 0 | May 15, 2026 |
| May 13, 2026 | Warburg Pincus & CO.+9 more | Director, 10% owner | open-market saleindirect | 19M | $15.17 | $290M | 0 | May 15, 2026 |
| May 13, 2026 | Gtcr Investment XI LLC+4 more | Director, 10% owner | open-market saleindirect | 13M | $15.17 | $193M | 0 | May 15, 2026 |
| Mar 31, 2026 | Dimitrief Alexander | Former SVP, GC and Sec. | tax withholding | 7,941 | $14.34 | $114K | 312,040 | Apr 2, 2026 |
| Mar 6, 2026 | Warburg Pincus Partners GP LLC+7 more | Director, 10% owner | open-market saleindirect | 15M | $15.27 | not summed | 19M | Mar 10, 2026 |
| Mar 6, 2026 | Warburg Pincus Partners II, L.P.+9 more | Director, 10% owner | open-market saleindirect | 15M | $15.27 | $229M | 19M | Mar 10, 2026 |
| Mar 6, 2026 | Gtcr Co-Invest XI LP+4 more | Director, 10% owner | open-market saleindirect | 10M | $15.27 | $153M | 13M | Mar 10, 2026 |
| Mar 2, 2026 | Petras Michael B. Jr. | Chairman & CEO, Director | tax withholding | 31,339 | $15.91 | $499K | 521,451 | Mar 4, 2026 |
| Mar 2, 2026 | Petras Michael B. Jr. | Chairman & CEO, Director | tax withholding | 40,302 | $15.91 | $641K | 481,149 | Mar 4, 2026 |
| Mar 2, 2026 | Petras Michael B. Jr. | Chairman & CEO, Director | award | 240,248 | $0.00 | — | 692,427 | Mar 4, 2026 |
| Mar 2, 2026 | Petras Michael B. Jr. | Chairman & CEO, Director | tax withholding | 39,552 | $15.91 | $629K | 531,283 | Mar 4, 2026 |
| Mar 2, 2026 | Petras Michael B. Jr. | Chairman & CEO, Director | tax withholding | 79,104 | $15.91 | $1M | 452,179 | Mar 4, 2026 |
| Mar 2, 2026 | Petras Michael B. Jr. | Chairman & CEO, Director | option exercise | 89,686 | — | — | 570,835 | Mar 4, 2026 |
| Mar 2, 2026 | Dimitrief Alexander | SVP, General Counsel and Sec. | tax withholding | 7,941 | $15.91 | $126K | 326,784 | Mar 4, 2026 |
| Mar 2, 2026 | Dimitrief Alexander | SVP, General Counsel and Sec. | tax withholding | 23,619 | $15.91 | $376K | 319,981 | Mar 4, 2026 |
| Mar 2, 2026 | Dimitrief Alexander | SVP, General Counsel and Sec. | option exercise | 16,816 | — | — | 343,600 | Mar 4, 2026 |
| Mar 2, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | tax withholding | 6,046 | $15.91 | $96K | 183,556 | Mar 4, 2026 |
| Mar 2, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | option exercise | 17,937 | — | — | 201,493 | Mar 4, 2026 |
| Mar 2, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | award | 59,355 | $0.00 | — | 228,620 | Mar 4, 2026 |
| Mar 2, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | tax withholding | 8,240 | $15.91 | $131K | 169,265 | Mar 4, 2026 |
| Mar 2, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | tax withholding | 23,988 | $15.91 | $382K | 177,505 | Mar 4, 2026 |
| Mar 2, 2026 | Rutz Michael P | President of Sterigenics | award | 45,223 | $0.00 | — | 484,279 | Mar 4, 2026 |
| Mar 2, 2026 | Rutz Michael P | President of Sterigenics | tax withholding | 17,497 | $15.91 | $278K | 439,056 | Mar 4, 2026 |
| Mar 2, 2026 | Rutz Michael P | President of Sterigenics | option exercise | 14,573 | — | — | 456,553 | Mar 4, 2026 |
| Mar 2, 2026 | Rutz Michael P | President of Sterigenics | tax withholding | 3,729 | $15.91 | $59K | 446,475 | Mar 4, 2026 |
| Mar 2, 2026 | Rutz Michael P | President of Sterigenics | tax withholding | 4,495 | $15.91 | $72K | 441,980 | Mar 4, 2026 |
| Dec 8, 2025 | Petras Michael B. Jr. | Chairman & CEO, Director | open-market sale | 315,896 | $16.45 | $5M | 552,790 | Dec 10, 2025 |
| Dec 8, 2025 | Petras Michael B. Jr. | Chairman & CEO, Director | open-market saleindirect | 394,861 | $16.45 | $6M | 5M | Dec 10, 2025 |
| Dec 8, 2025 | Petras Michael B. Jr. | Chairman & CEO, Director | open-market saleindirect | 39,243 | $16.45 | $646K | 0 | Dec 10, 2025 |
| Dec 3, 2025 | Warburg Pincus LLC+7 more | Director, 10% owner | open-market saleindirect | 10M | $16.33 | not summed | 34M | Dec 5, 2025 |
| Dec 3, 2025 | Warburg Pincus Partners GP LLC+7 more | Director, 10% owner | open-market saleindirect | 10M | $16.33 | $159M | 34M | Dec 5, 2025 |
| Dec 3, 2025 | Gtcr Fund Xi/a LP+4 more | Director, 10% owner | open-market saleindirect | 6M | $16.33 | $106M | 23M | Dec 5, 2025 |
| Nov 10, 2025 | Gtcr Fund Xi/a LP+4 more | Director, 10% owner | open-market saleindirect | 12M | $15.65 | $188M | 29M | Nov 12, 2025 |
| Nov 10, 2025 | Warburg Pincus Private Equity XI-C, L.P.+7 more | Director, 10% owner | open-market saleindirect | 18M | $15.65 | not summed | 44M | Nov 12, 2025 |
Who the insiders are
Everyone who reported a transaction since November 16, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Warburg Pincus & CO. | Director, 10% owner | May 13, 2026 | open-market sale | — | — | $580M (2) | 0 of 2 |
| Warburg Pincus Partners II, L.P. | Director, 10% owner | Mar 6, 2026 | open-market sale | — | — | $229M (1) | 0 of 1 |
| Gtcr Investment XI LLC | Director, 10% owner | May 13, 2026 | open-market sale | — | — | $193M (1) | 0 of 1 |
| Warburg Pincus Partners GP LLC | Director, 10% owner | Mar 6, 2026 | open-market sale | — | — | $159M (2) | 0 of 2 |
| Gtcr Co-Invest XI LP | Director, 10% owner | Mar 6, 2026 | open-market sale | — | — | $153M (1) | 0 of 1 |
| Gtcr Fund Xi/a LP | Director, 10% owner | Dec 3, 2025 | open-market sale | — | — | $106M (1) | 0 of 1 |
| Petras Michael B. Jr. | Executive Chairman, Director | Aug 17, 2026 | open-market sale | 397,912 | — | $34M (5) | 0 of 5 |
| Rutz Michael P | President of Sterigenics | Aug 7, 2026 | open-market sale | 334,279 | — | $3M (1) | 0 of 1 |
| Lyons Jonathan M. | Sr. Vice President, CFO | Aug 5, 2026 | tax withholding | 217,304 | — | — | — |
| Dimitrief Alexander | Former SVP, GC and Sec. | Mar 31, 2026 | tax withholding | 312,040 | — | — | — |
| Shader Alton | Chief Executive Officer, Director | May 26, 2026 | award | 375,939 | — | — | — |
| Klee Ann R. | Director | May 22, 2026 | award | 140,926 | — | — | — |
| Cunningham Sean Laurence | Director | May 22, 2026 | award | 95,751 | — | — | — |
| Flynn Karen | Director | May 22, 2026 | award | 54,191 | — | — | — |
| Neary James | Director | May 22, 2026 | award | 95,751 | — | — | — |
| Petrella Vincent K | Director | May 22, 2026 | award | 95,751 | — | — | — |
| Chen Ruoxi | Director | May 22, 2026 | award | 95,751 | — | — | — |
| Simon, Christopher | Director | May 22, 2026 | award | 34,102 | — | — | — |
| Wheadon David E. | Director | May 22, 2026 | award | 89,882 | — | — | — |
| Kyle Richard G | Director | May 22, 2026 | award | 14,970 | — | — | — |
| Krause Kenneth D. | Director | May 22, 2026 | award | 14,970 | — | — | — |
| Warburg Pincus LLC | Director, 10% owner | Dec 3, 2025 | open-market sale | — | — | $0 (1) | 0 of 1 |
| Warburg Pincus Private Equity XI-C, L.P. | Director, 10% owner | Nov 10, 2025 | open-market sale | — | — | — | — |
| Warburg Pincus XI-C, LLC | Director, 10% owner | Sep 5, 2025 | open-market sale | — | — | — | — |
| Knauss Robert Brown | Director | May 22, 2025 | award | 54,933 | — | — | — |
| Mihas Constantine S | Director | May 22, 2025 | award | 80,781 | — | — | — |
Questions
Are Sotera Health Company Common Stock insiders buying or selling?
Over the twelve months to November 16, 2026, 9 insiders at Sotera Health Company Common Stock sold $1.5B of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $1.5B. Only open-market purchases and sales are counted.
Who sold the most Sotera Health Company Common Stock stock in the last year?
Warburg Pincus & CO. (Director, 10% owner) sold $580M in 2 open-market sales over the twelve months to November 16, 2026.
Do Sotera Health Company Common Stock executives sell under 10b5-1 plans?
0 of the 15 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Sotera Health Company Common Stock
- Sotera Health Company Common Stock financial statements
- 1 tracked fund holding SHC
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.